Literature DB >> 14574120

Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats.

A M L Coenen1, E L J M Van Luijtelaar.   

Abstract

Based on the reviewed literature and the data presented in this paper, conclusions can be drawn with respect to the validity of the WAG/Rij strain of rats as a model for absence epilepsy in humans. The view that the WAG/Rij model has "face validity" is supported by the simultaneous presence of clinical and electroencephalographic signs characterizing absences in rat and humans, by the decrease in responsiveness during the presence of spike-wave discharges in both species, by the agreement between model and patient with respect to the preferential occurrences of spike-wave discharges at transitions in states of vigilance, by the corresponding modulation of spike-wave discharges by physical and mental activities in both and, finally, by the fact that in both humans and rats absence epilepsy is inherited. Against this view, however, argue two points. In rats, absences appear after puberty and are maintained during life, while in humans the seizures occur before puberty and then disappear or convert to more serious forms of epilepsy. The second point is the frequency difference of the spikes and waves in the discharge train: 8-10 Hz in the rat and 3 Hz in the human (though there are no a priori reasons why the frequency of spike waves in the burst must be the same in all species). The absence model also has predictive validity, based on pharmacological data that demonstrate the specificity of certain drugs as being effective in convulsive epilepsies and not in absence epilepsy. So far, all drugs affect spike-wave activity the same way in rats and humans, with lamotrigine being, perhaps, the only exception. Furthermore, sleep deprivation is a powerful provocation for the initiation of spike-wave discharges in both rats and humans. Potential explanations for the presence of absence seizures in rats have been found at the levels of activities in networks and nuclei; of neurons, membrane properties, and ion channels; of proteins and enzymes; and, finally, of genes and chromosomes. Further descriptions of the cellular processes can be found extensively in the literature (e.g., McCormick and Contreras, 2001) and those of the thalamo-cortico-thalamic network in this review as well as in others (Avanzini et al., 1999). Considering the extensive involvement of the phenomena under study with theoretical issues such as the relationship between sleep spindles and spike-wave discharges, and the origin of seizure activity, it can be concluded that the model also has construct validity as far as the present neurobiological theories holding for absence epilepsy in humans are concerned. The WAG/Rij model can therefore be recommended for continued use in evaluating antiepileptic drugs for monotherapy and polytherapy, as well as for the toxicological side effects of putative new antiabsence drugs.

Entities:  

Mesh:

Year:  2003        PMID: 14574120     DOI: 10.1023/a:1026179013847

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  110 in total

1.  Reticular nucleus-specific changes in alpha3 subunit protein at GABA synapses in genetically epilepsy-prone rats.

Authors:  Xiao-Bo Liu; Jeffrey Coble; Gilles van Luijtelaar; Edward G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-13       Impact factor: 11.205

2.  Head-to head comparison of mGlu1 and mGlu5 receptor activation in chronic treatment of absence epilepsy in WAG/Rij rats.

Authors:  V D'Amore; I Santolini; R Celli; L Lionetto; A De Fusco; M Simmaco; C M van Rijn; E Vieira; S R Stauffer; P J Conn; P Bosco; F Nicoletti; G van Luijtelaar; R T Ngomba
Journal:  Neuropharmacology       Date:  2014-05-20       Impact factor: 5.250

3.  Where fMRI and electrophysiology agree to disagree: corticothalamic and striatal activity patterns in the WAG/Rij rat.

Authors:  Asht Mangal Mishra; Damien J Ellens; Ulrich Schridde; Joshua E Motelow; Michael J Purcaro; Matthew N DeSalvo; Miro Enev; Basavaraju G Sanganahalli; Fahmeed Hyder; Hal Blumenfeld
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

4.  Intracellular activity of cortical and thalamic neurones during high-voltage rhythmic spike discharge in Long-Evans rats in vivo.

Authors:  Pierre-Olivier Polack; Stéphane Charpier
Journal:  J Physiol       Date:  2006-01-12       Impact factor: 5.182

5.  A role for the preoptic sleep-promoting system in absence epilepsy.

Authors:  N Suntsova; S Kumar; R Guzman-Marin; M N Alam; R Szymusiak; D McGinty
Journal:  Neurobiol Dis       Date:  2009-07-23       Impact factor: 5.996

6.  Functional neuroimaging of spike-wave seizures.

Authors:  Joshua E Motelow; Hal Blumenfeld
Journal:  Methods Mol Biol       Date:  2009

7.  Altered Cortical and Hippocampal Excitability in TgF344-AD Rats Modeling Alzheimer's Disease Pathology.

Authors:  Milan Stoiljkovic; Craig Kelley; Bernardo Stutz; Tamas L Horvath; Mihály Hajós
Journal:  Cereb Cortex       Date:  2019-06-01       Impact factor: 5.357

8.  Functional definition of seizure provides new insight into post-traumatic epileptogenesis.

Authors:  Raimondo D'Ambrosio; Shahin Hakimian; Tessandra Stewart; Derek R Verley; Jason S Fender; Clifford L Eastman; Aaron H Sheerin; Puneet Gupta; Ramon Diaz-Arrastia; Jeffrey Ojemann; John W Miller
Journal:  Brain       Date:  2009-09-15       Impact factor: 13.501

9.  Heterozygous mutations of the voltage-gated sodium channel SCN8A are associated with spike-wave discharges and absence epilepsy in mice.

Authors:  Ligia A Papale; Barbara Beyer; Julie M Jones; Lisa M Sharkey; Sergio Tufik; Michael Epstein; Verity A Letts; Miriam H Meisler; Wayne N Frankel; Andrew Escayg
Journal:  Hum Mol Genet       Date:  2009-03-02       Impact factor: 6.150

10.  Identifying neural drivers with functional MRI: an electrophysiological validation.

Authors:  Olivier David; Isabelle Guillemain; Sandrine Saillet; Sebastien Reyt; Colin Deransart; Christoph Segebarth; Antoine Depaulis
Journal:  PLoS Biol       Date:  2008-12-23       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.